ArticleFrontiers in pharmacology2024

A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm

Sisi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.